TechNavio's analysts forecast the Biochips market in North America to grow at a CAGR of 10.24 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for high-speed diagnosis. The Biochips market in North America has also been witnessing the increasing outsourcing activities by drug manufacturers. However, the high cost incurred in the implementation of biochips could pose a challenge to the growth of this market.
TechNavio's report, the Biochips Market in North America 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on North America; it also covers the Biochips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Becton, Dickinson and Co., bioMérieux S.A., BioRad Laboratories, Cepheid Inc., Danaher Corp., GE Healthcare Ltd., Microarrays Inc., Qiagen N.V, Promega Corp., Illumina Inc., Life Technologies Corp., Roche Holding AG, Perkin Elmer Inc., and Siemens Healthcare Diagnostics.
Key questions answered in this report:
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.